NASDAQ •
Healthcare •
Medical Devices •
Quote as of 06/22/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6.97 mln
Float8.69 mln
Earnings Date08/31/2026
1-Year Forecast
5.00
Transformational upside
Relative Strength
4
/ 100
Severely lagging
Debt / Equity
0.34
Low leverage
ROE
-367
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
20/20 GeneSystems is a Maryland-based medical testing company that helps detect cancer early through blood tests and provides tools to identify viral infections like COVID-19. Beyond direct testing, it runs a shared laboratory facility where new diagnostic companies can develop and launch their products in the U.S. market. It also works with healthcare providers to deliver its cancer screening technology through a software platform.
